PMID: 15232332Jul 3, 2004Paper

Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence

Journal of Clinical Psychopharmacology
Christian R DolderD V Jeste

Abstract

The purpose of this study was to develop and test a brief scale (Brief Evaluation of Medication Influences and Beliefs [BEMIB]) designed to identify patients who are more likely to be nonadherent to their antipsychotic medication. Sixty-three outpatients with schizophrenia and related psychotic disorders were enrolled and given an assessment battery including the BEMIB, a previously published adherence scale, extrapyramidal symptom rating scales, and an adherence assessment with patient self-report and prescription refill records. The BEMIB consisted of 8 statements derived from the health belief model with a 5-point Likert-type scale for each statement. Subjects chose a single answer for each item depending on their level of agreement or disagreement. According to refill records, subjects meeting BEMIB-based criteria for nonadherence had significantly larger gaps in antipsychotic therapy (greater nonadherence) compared with those of participants not meeting criteria for nonadherence. For the 1-week test-retest reliability, the BEMIB total score and 5 of 8 single items correlated significantly. BEMIB total scores correlated significantly with an established assessment of adherence (Drug Attitude Inventory), demonstrating adequa...Continue Reading

References

Jan 1, 1991·Journal of Clinical Epidemiology·J F SteinerT S Inut
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Jan 1, 1984·Health Education Quarterly·N K Janz, M H Becker
Dec 1, 1982·Epilepsia·G M PetersonK S Millingen
Jan 1, 1994·Schizophrenia Bulletin·P WeidenA Frances
Jan 1, 1997·Journal of Clinical Epidemiology·J F Steiner, A V Prochazka
Jan 1, 1997·Schizophrenia Bulletin·W S FentonR K Heinssen
Jul 29, 1998·The Annals of Pharmacotherapy·R E GrymonpreD S Sitar
May 4, 1999·Acta Psychiatrica Scandinavica. Supplementum·J Gerlach, E B Larsen
Oct 6, 2000·Controlled Clinical Trials·M Z VitolinsM A Sevick
Feb 24, 2001·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·H YamadaJ Fujii
Jan 5, 2002·The American Journal of Psychiatry·Christian R DolderDilip V Jeste
Jan 14, 2003·The Journal of Clinical Psychiatry·Diana O Perkins

❮ Previous
Next ❯

Citations

Oct 30, 2013·International Journal of Clinical Pharmacy·Audrey LehmannMarie Paule Schneider
Jan 5, 2013·Clinical Drug Investigation·Fernando CañasMiquel Roca
May 19, 2006·Schizophrenia Bulletin·Dawn I VelliganAlexander L Miller
Oct 28, 2008·The Journal of Cardiovascular Nursing·John X RolleyYenna Salamonson
Jun 17, 2008·Current Medical Research and Opinion·Steven R HahnPeggy W Flowers
May 5, 2011·Journal of Psychiatric and Mental Health Nursing·H LeeC J Jolley
Apr 7, 2010·American Heart Journal·Nancy M Allen LaPointeEric D Peterson
Nov 1, 2011·BMC Complementary and Alternative Medicine·Nicole J BushettPene Wood
Oct 23, 2012·Revista de psiquiatrí́a y salud mental·Francisco AcostaBeatriz Cabrera
Oct 10, 2007·Harvard Review of Psychiatry·Brian PomykaczChristian J Teter
Feb 5, 2011·Journal of Psychopharmacology·Thomas R E Barnes, UNKNOWN Schizophrenia Consensus Group of British Association for Psychopharmacology
Jan 29, 2011·Scandinavian Journal of Public Health·Annelie K GusdalLena Törnkvist
Jun 4, 2010·Journal of Clinical Psychopharmacology·Halldóra JónsdóttirOle A Andreassen
Nov 1, 2013·World Journal of Psychiatry·Francisco Javier AcostaCarlos J Rodríguez
May 16, 2019·Psychiatric Services : a Journal of the American Psychiatric Association·Delbert G RobinsonJohn M Kane
Jul 11, 2012·The International Journal of Pharmacy Practice·Gordon F RushworthStephen J Leslie
Jun 28, 2013·British Journal of Clinical Pharmacology·Thi-My-Uyen NguyenNeil Cottrell
Oct 9, 2020·Journal of Medical Internet Research·Yu Heng KwanJulian Thumboo
Oct 10, 2020·Journal of Medical Internet Research·Yu Heng KwanJulian Thumboo
Nov 25, 2020·Health Services Research·Daniel Bennett, Robert Rosenheck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here